ArticleJournal of molecular medicine (Berlin, Germany)2017

Sequential combination of docetaxel with a SHP-1 agonist enhanced suppression of p-STAT3 signaling and apoptosis in triple negative breast cancer cells.

Chun-Yu Liu et al.PubMed ↗Publisher ↗

No numbers read from the abstract.